Expert Video - Who is eligible for TIL therapy? What are the criteria?

Rekha Chaudhary, MD, a hematologist and oncologist who specializes in the treatment of melanoma at the University of Cincinnati, explains some of the important criteria that make a melanoma patient eligible for tumor infiltrating lymphocyte (TIL) therapy. Patients need a tumor large enough and accessible enough to biopsy for TIL therapy. They also need to be healthy enough to undergo the chemotherapy, or lymphodepletion, as well as the IL-2 infusions to receive the TIL therapy.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about melanoma which will help other patients, caregivers and families.

Other Modules:


This educational activity has been developed by the Melanoma Research Foundation (MRF), and Mechanisms in Medicine Inc.

This activity is supported by independent educational grants from Bristol-Myers Squibb, Foundation Medicine, Genentech, Iovance Biotherapeutics, Merck, Natera, and Novartis.

Bristol-Myers Squibb
Foundation Medicine

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.